Version 2 2021-09-08, 14:30Version 2 2021-09-08, 14:30
Version 1 2019-08-27, 16:16Version 1 2019-08-27, 16:16
journal contribution
posted on 2021-09-08, 14:27authored byM Sweeting, LG Kim, D Epstein, M Venermo, FEV Rohlffs, RM Greenhalgh
Background:
EVAR for abdominal aortic aneurysm has an initial survival advantage over OR, but more frequent complications increase costs and long-term aneurysm-related mortality. Randomized controlled trials of EVAR versus OR have shown EVAR is not cost-effective over a patient's lifetime. However, in the EVAR-1 trial, postoperative surveillance may have been sub-optimal, as the importance of sac growth as a predictor of graft failure was overlooked.
Methods:
Real-world data informed a discrete event simulation model of postoperative outcomes following EVAR. Outcomes observed EVAR-1 were compared with those from 5 alternative postoperative surveillance and re-intervention strategies. Key events, quality-adjusted life years and costs were predicted. The impact of using complication and rupture rates from more recent devices, imaging and re-intervention methods was also explored.
Results:
Compared with observed EVAR-1 outcomes, modeling full adherence to the EVAR-1 scan protocol reduced abdominal aortic aneurysm (AAA) deaths by 3% and increased elective re-interventions by 44%. European Society re-intervention guidelines provided the most clinically effective strategy, with an 8% reduction in AAA deaths, but a 52% increase in elective re-interventions. The cheapest and most cost-effective strategy used lifetime annual ultrasound in primary care with confirmatory computed tomography if necessary, and reduced AAA-related deaths by 5%. Using contemporary rates for complications and rupture did not alter these conclusions.
Conclusions:
All alternative strategies improved clinical benefits compared with the EVAR-1 trial. Further work is needed regarding the cost and accuracy of primary care ultrasound, and the potential impact of these strategies in the comparison with OR.
Funding
Financial support from National Institute of Health Research and Camelia Botnar Arterial Foundation.
The National Institute of Health Research (NIHR) had no role in study design, data collection, data
analysis, data interpretation, in the writing of the report or in the decision to submit the article for
publication. The views and opinions expressed herein are those of the authors and do not necessarily
reflect those of the NIHR, UK NHS, or Department of Health. The corresponding author had full access
to all the data in the study and had final responsibility for the decision to submit for publication.
History
Citation
Annals of Surgery, 2019, doi: 10.1097/SLA.0000000000003625
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences
Version
VoR (Version of Record)
Published in
Annals of Surgery
Publisher
Lippincott, Williams & Wilkins, American Surgical Association, European Surgical Association